Clinical Trial Update: Rituximab, Cyclophosphamide, Bortezomib, and Prednisone in Patients With Stage III/IV FL or MZL [NA]

View source ↗

Summary

The study evaluated a Rituximab, Cyclophosphamide, Bortezomib, and Prednisone regimen in patients with stage III/IV follicular lymphoma or marginal zone lymphom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma
• Marginal Zone Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• PREDNISONE (Prednisone)
• Rituximab (rituximab)
• Velcade (bortezomib)

Snippet

Sponsor: University of Miami | Conditions: Lymphoma, Follicular Lymphoma | NA | Status: TERMINATED | Results posted: 2013-02-21